EGFL8 anticorps

N° du produit ABIN7239866

Détail du produit anti-EGFL8 anticorps

Antigène: EGFL8 (EGF-Like-Domain, Multiple 8 (EGFL8))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EGFL8 est non-conjugé

Application: Immunohistochemistry (IHC), ELISA

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant protein of human EGFL8

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur EGFL8

Antigène: EGFL8 (EGF-Like-Domain, Multiple 8 (EGFL8))

Autre désignation: EGFL8 (EGFL8 Produits)

Synonymes: anticorps ng3, anticorps ppt2, anticorps MGC145308, anticorps Ng3, anticorps C6orf8, anticorps NG3, anticorps EGF like domain multiple 8, anticorps EGF-like domain 8, anticorps EGF-like-domain, multiple 8, anticorps EGFL8, anticorps egfl8, anticorps Egfl8

Sujet: The epidermal growth factor (EGF) repeat-containing proteins constitute an expanding family of proteins that are involved in several cellular activities, such as blood coagulation, fibrinolysis, cell adhesion, and neural and vertebrate development. EGFL8 (EGF-like domain-containing protein 8), also known as C6orf8, NG3 and VE-statin-2, is a 293 amino acid secreted protein that contains two EGF-like domains and one EMI domain. Via its EGF and EMI domains, EGFL8 may participate in protein-protein interactions that correlate with cellular proliferation and developmental signaling events. In mice, EGFL8 is expressed predominately in brain, kidney, lung and thymus.

UniProt: Q99944